Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOLVAPTAN vs TOREMIFENE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TOLVAPTAN vs TOREMIFENE: Safety Overview

Metric TOLVAPTAN TOREMIFENE
Total FAERS Reports 9,014 245
Deaths Reported 1,709 16
Death Rate 19.0% 6.5%
Hospitalizations 2,467 92
Average Patient Age 56.2 yrs 61.7 yrs
% Female Patients 52.0% 95.0%
FDA Approval Date Apr 23, 2018 Aug 18, 2020
Manufacturer Otsuka America Pharmaceutical, Inc. Kyowa Kirin, Inc.
Route ORAL ORAL
Marketing Status Prescription Discontinued